#JustIn | Dr Reddy’s arm Aurigene Oncology announces phase 1 results for Ribrecabtagene Autoleucel from SWASTH study. Drugs Controller General of India (DCGI) gives nod to commence phase 2 part of the trial

🎗October is #BreastCancerAwarenessMonth and ‘Awareness Is The First Step To #Prevention'🎗 Together we can make a difference by: 🌸 Raising awareness 🌸 Supporting research 🌸 Encouraging regular screenings #BreastCancerAwareness #BreastCancer #Cancer #Oncology #WomensHealth

October is #BreastCancerAwarenessMonth. Let’s raise #awareness and advance progress in #BreastCancerResearch and care. 🎗️Get Screened: Early detection saves life 🎗️Spread the word: Share authentic facts and resources 🎗️Support Survivors: Support those battling #BreastCancer

#India observes November 7th as #NationalCancerAwarenessDay to spread #awareness about #Cancer. By encouraging check-ups, and supporting #research, we can reduce cancer’s impact and improve lives. Empower, Educate, Eradicate. Together, We Can Conquer #Cancer. #Oncology #Health

Future of healthcare is being transformed by #CellandGeneTherapy. At #BengaluruTechSummit 2024,hosted by ITBT Karnataka, industry leaders—including our CEO Dr.Murali Ramachandra will explore how these innovations are revolutionizing medicine. STPI MM Activ Sci-Tech Communications #BTS2024 #BTSUnbound

We are thrilled to share that Olema Oncology has been granted the clearance by U.S. FDA for the Investigational New Drug (IND) application for #KAT6 inhibitor: OP-3136, a promising therapeutic candidate which has come out of a collaboration with Aurigene Oncology Ltd

We stand for developing affordable and innovative pharmaceuticals by investing in the latest science and technology, developing great scientists and creating an environment that nurtures innovation in all aspects of product development. In this episode of #ScientistInSpotlight,

Our 40th was indeed a landmark year for us – steady performance across markets in our base business, bold early strides in our future growth drivers of access to new molecules, digital therapeutics and consumer health, and strategic collaborations with partners across the board.

We are excited to share that our CEO Dr. Murali Ramachandra will be speaking at Biotech Showcase and present Aurigene Oncology Ltd's innovative pipeline along with our roadmap to commercialization. Demy Colton EBD Group #Partnership #Funding #Oncology #BusinessDevelopment #Cancer

On #WorldCancerDay, we stand united with the global community in the fight against #cancer. We are committed to advancing research, innovation, and collaboration to transform cancer treatment and improve patient outcomes. Together we can make a difference. #UnitedbyUnique

We are pleased to share that our CEO Dr. Murali Ramachandra will be speaking at the 4th East-West Biopharma Summit! BioCentury #BioCenturyEastWest #OncologyPipeline #Partnership #BusinessDevelopment #Strategy #Leadership #OncologyConferences #DrugDiscovery #Innovation #Singapore

🔬 Session IX: Anti-cancer Therapeutics & Prevention of Relapse wrapped up with: ✅ Dr. Murali Ramachandra (Aurigene Oncology Ltd ) – Pan-KRAS degrader discovery ✅ Dr. Neeraj Jain (CSIR-CDRI ) – Chemotherapy resistance & immune escape in B-cell Lymphoma #CTDDR2025 #Drugdiscovery

We are delighted to share that our oral presentation on the SWASTH Phase-I trial and the poster presentation on cost-effective CAR-T #manufacturing has secured top honors at the recently held SACT 2025 (Series on Advancements in Cell Therapy) These achievements underscore dedication of our #scientists and #clinicians.

Our Chief Scientific Officer, Dr. Susanta Samajdar will be presenting three groundbreaking research posters at the AACR annual meeting 2025! Join us for engaging discussions on #innovation, business and valuable #networking! #CancerResearch #Oncology

Dr. Murali Ramachandra (CEO, Aurigene Oncology Ltd) shared his awe-inspiring career trajectory from academia & agriculture, to #DrugDiscovery & #leadership in #industry. His research underscores the role of #innovation, data-backed optimism & perseverence in #DrugDevelopment #BioE3

Aurigene Oncology Ltd is participating in #BIO2025, Biotechnology Innovation Organization, from June 16-19, 2025. We are looking forward to discussions with potential partners for our clinical/preclinical stage assets and #discoveryplatforms. Please reach out to our BD team to set up a meeting! #CancerPipeline